Related MeSH Hierarchy (8)
Diseases [C] » Urogenital Diseases [C12] » Female Urogenital Diseases and Pregnancy Complications » Female Urogenital Diseases » Urogenital Neoplasms » Urologic Neoplasms » Urethral Neoplasms
Diseases [C] » Urogenital Diseases [C12] » Female Urogenital Diseases and Pregnancy Complications » Female Urogenital Diseases » Urologic Diseases » Urethral Diseases » Urethral Neoplasms
Diseases [C] » Urogenital Diseases [C12] » Male Urogenital Diseases » Urogenital Neoplasms » Urologic Neoplasms » Urethral Neoplasms
Diseases [C] » Urogenital Diseases [C12] » Male Urogenital Diseases » Urologic Diseases » Urethral Diseases » Urethral Neoplasms
Diseases [C] » Urogenital Diseases [C12] » Urogenital Neoplasms » Urologic Neoplasms » Urethral Neoplasms
Diseases [C] » Urogenital Diseases [C12] » Urologic Diseases » Urethral Diseases » Urethral Neoplasms
Diseases [C] » Urogenital Diseases [C12] » Urologic Diseases » Urologic Neoplasms » Urethral Neoplasms
Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Urogenital Neoplasms » Urologic Neoplasms » Urethral Neoplasms
Description
Cancer or tumors of the URETHRA. Benign epithelial tumors of the urethra usually consist of squamous and transitional cells. Primary urethral carcinomas are rare and typically of squamous cells. Urethral carcinoma is the only urological malignancy that is more common in females than in males. MeSH
Hierarchy View
Phase 3 Indicated Drugs (14)
Phase 2 Indicated Drugs (38)
Phase 1 Indicated Drugs (7)
Organization Involved with Phase 3 Indications (24)
Cancer and Leukemia Group B (CALGB)
Central European Cooperative Oncology Group
German Association of Urologic Oncology
Groupe D'Etude des Tumeurs Uro-Genitales
Organization Involved with Phase 1 Indications (13)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
